Alfavision Overseas (India) Ltd
₹11.28
+0.08 (0.71%)
Thu, 22 Oct 2026, 07:47 pm
Health Technology
Biotechnology
24.5KAlfavision Overseas (India) Return on Equity (ROE) History
| Particulars | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 9.35 | 10.69 | 10.11 | 67.57 | 100 | 130.91 | 44.78 | 37.04 | 121.18 | 78.31 | 70.74 | 74.34 | 68.71 | 47.57 | 8.76 | 20.38 | 49.58 | 161.80 | 332.38 |
| Price to book ratio | 1.52 | 0.92 | 0.56 | 1.25 | 1.33 | 1.40 | 1.41 | 1.36 | 4.48 | 2.73 | 2.52 | 1.95 | 1.32 | 0.95 | 1.23 | 0.90 | 0.81 | 1.07 | 0.96 |
| Price to sales ratio | 3.78 | 1.97 | 0.68 | 1.28 | 2.31 | 1.59 | 0.38 | 0.25 | 0.67 | 0.65 | 0.62 | 0.16 | 0.09 | 0.05 | 0.07 | 0.23 | 1.10 | 14.30 | 21.22 |
| Price to cash flow ratio | 37.09 | 0 | 0 | 0 | 0 | 8.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 90.53 |
| Enterprise value | 7.84Cr | 5.54Cr | 5.09Cr | 9.39Cr | 11Cr | 10.72Cr | 12.62Cr | 12.72Cr | 36.09Cr | 22.57Cr | 24.94Cr | 41.52Cr | 41.62Cr | 60.17Cr | 70.28Cr | 183Cr | 159Cr | 169Cr | 165Cr |
| Enterprise value to EBITDA ratio | 10.58 | 11.20 | 21.40 | 0 | 0 | 0 | 228.81 | 116.09 | 164.80 | 88.42 | 41.46 | 21.40 | 17.27 | 17.95 | 17.51 | 37.08 | 69.62 | 176.20 | 1140 |
| Debt to equity ratio | 0 | 0.09 | 0.27 | 0.24 | 0.42 | 0.29 | 0.50 | 0.50 | 0.61 | 0.32 | 0.70 | 3.01 | 3.54 | 5.82 | 5.56 | 3.14 | 3 | 2.96 | 2.95 |
| Return on equity % | 0 | 8.55 | 5.70 | 1.89 | 1.32 | 1.09 | 3.22 | 3.75 | 3.78 | 3.56 | 3.64 | 2.70 | 1.94 | 2.01 | 15.16 | 7.26 | 1.56 | 0.65 | 0.29 |
Alfavision Overseas (India) Ltd Return on Equity
The Alfavision Overseas (India) Ltd Return on Equity is a key financial metric used by investors to evaluate Alfavision Overseas (India) Ltd's valuation, profitability, and overall financial performance. Tracking the Alfavision Overseas (India) Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Alfavision Overseas (India) Ltd (NSE: , BSE: 531156) is currently trading at ₹11.28, with a market capitalization of ₹35.31Cr. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Alfavision Overseas (India) Ltd Return on Equity is essential for fundamental analysis.
Alfavision Overseas (India) Ltd Return on Equity Current Value
The current Alfavision Overseas (India) Ltd Return on Equity stands at 0.29.
The Alfavision Overseas (India) Ltd Return on Equity has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Alfavision Overseas (India) Ltd Return on Equity Historical Trend
The Alfavision Overseas (India) Ltd Return on Equity has shown the following historical trend:
- 2025: 0.29
- 2024: 0.65
- 2023: 1.56
- 2022: 7.26
- 2021: 15.16
The decline in Alfavision Overseas (India) Ltd Return on Equity indicates improving financial efficiency or better earnings growth.
What Alfavision Overseas (India) Ltd Return on Equity Indicates for Investors
The Alfavision Overseas (India) Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Alfavision Overseas (India) Ltd Return on Equity Analysis Summary
The Alfavision Overseas (India) Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Alfavision Overseas (India) Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Alfavision Overseas (India) Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
